AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Vera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 09:30 am Purchase |
2024-12-31 | 13G | Vera Therapeutics, Inc. VERA |
AVORO CAPITAL ADVISORS LLC | 5,610,000 8.900% |
1,300,410![]() (+30.17%) |
Filing |
2024-11-14 09:35 am Purchase |
2024-09-30 | 13G | Vera Therapeutics, Inc. VERA |
AVORO CAPITAL ADVISORS LLC | 4,309,590 7.900% |
4,309,590![]() (New Position) |
Filing |